Literature DB >> 3623718

Cell shape modulation alters glycosylation of a metastatic melanoma cell-surface antigen.

I R Nabi, A Raz.   

Abstract

B16-F1 melanoma cells cultivated in vitro as spheroids on a non-adhesive substrate acquire in a reversible fashion an increase in lung colonization in vivo as compared to cells cultured as a monolayer. After neuraminidase treatment of protein blots, the spheroidal cells expressed an increased binding of 125I-labelled peanut lectin (PNA) to a unique glycoprotein of Mr 78,000 (gp78) which after desialylation migrated in SDS-polyacrylamide gels as an Mr 86,000 protein. Antibodies were generated against this glycoprotein purified on PNA-Sepharose and its expression on the surface of viable B16-F1 cells was demonstrated. Growth of B16-F1 melanoma cells in suspension is associated with the altered glycosylation of gp78 which may be related to the increased metastatic ability of these cells. In vitro treatment of B16-F1 cells with anti-gp78 Fab fragments prior to their injection into the tail veins of syngeneic mice resulted in a 2-fold increase in the appearance of tumor lung colonies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3623718     DOI: 10.1002/ijc.2910400319

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

Review 1.  E3 ubiquitin ligases in protein quality control mechanism.

Authors:  Deepak Chhangani; Ajay Prakash Joshi; Amit Mishra
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

2.  Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.

Authors:  S Silletti; S Paku; A Raz
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

3.  Metastasis-associated protein 1 drives tumor cell migration and invasion through transcriptional repression of RING finger protein 144A.

Authors:  Hezlin Marzook; Da-Qiang Li; Vasudha S Nair; Prakriti Mudvari; Sirigiri Divijendra Natha Reddy; Suresh B Pakala; T R Santhoshkumar; M Radhakrishna Pillai; Rakesh Kumar
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

4.  The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum.

Authors:  S Fang; M Ferrone; C Yang; J P Jensen; S Tiwari; A M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

Review 5.  Autocrine factors, type IV collagenase secretion and prostatic cancer cell invasion.

Authors:  M E Stearns; M Stearns
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

6.  Characterization of deoxyguanosine-resistant hypoxanthine-guanine phosphoribosyltransferase(-)metastatic variants altered in soybean-agglutinin-binding properties and cell-surface glycoproteins.

Authors:  J E Damen; M A Spearman; A H Greenberg; J A Wright
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

7.  Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRDeltaF508.

Authors:  Daisuke Morito; Kazuyoshi Hirao; Yukako Oda; Nobuko Hosokawa; Fuminori Tokunaga; Douglas M Cyr; Keiji Tanaka; Kazuhiro Iwai; Kazuhiro Nagata
Journal:  Mol Biol Cell       Date:  2008-01-23       Impact factor: 4.138

8.  Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.

Authors:  S Silletti; S Paku; A Raz
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

Review 9.  Autocrine motility factor and its receptor: role in cell locomotion and metastasis.

Authors:  I R Nabi; H Watanabe; A Raz
Journal:  Cancer Metastasis Rev       Date:  1992-03       Impact factor: 9.264

10.  Autocrine motility factor stimulates the invasiveness of malignant cells as well as up-regulation of matrix metalloproteinase-3 expression via a MAPK pathway.

Authors:  Arayo Haga; Tatsuyoshi Funasaka; Yoshihiro Deyashiki; Avraham Raz
Journal:  FEBS Lett       Date:  2008-05-15       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.